Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KRANCE, Robert A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationLEEN, Ann M; CHRISTIN, Anne; BRENNER, Malcolm K et al.Blood. 2009, Vol 114, Num 19, pp 4283-4292, issn 0006-4971, 10 p.Article

Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous diseaseMARTINEZ, Caridad A; SHAH, Sweta; HAO LIU et al.Journal of allergy and clinical immunology. 2012, Vol 129, Num 1, pp 176-183, issn 0091-6749, 8 p.Article

Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytesPAKAKASAMA, Samart; EAMES, Gretchen M; MORRISS, Michael C et al.Transplantation. 2004, Vol 78, Num 5, pp 755-757, issn 0041-1337, 3 p.Article

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemiaVEYS, Paul; WYNN, Robert F; DUERST, Reggie E et al.Blood. 2012, Vol 119, Num 25, pp 6155-6161, issn 0006-4971, 7 p.Article

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy AdultsDRISCOLL, Timothy A; FRANGOUL, Haydar; NEMECEK, Eneida R et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5780-5789, issn 0066-4804, 10 p.Article

Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic ActivityKENNEDY-NASSER, Alana A; KU, Stephanie; SAVOLDO, Barbara et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2215-2225, issn 1078-0432, 11 p.Article

Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningPATEL, Niraj C; CHINEN, Javier; FOSTER, Samuel B et al.Journal of allergy and clinical immunology. 2009, Vol 124, Num 5, pp 1062-1069, issn 0091-6749, 8 p.Article

Inducible Apoptosis as a Safety Switch for Adoptive Cell TherapyDI STASI, Antonio; TEY, Siok-Keen; HAO LIU et al.The New England journal of medicine. 2011, Vol 365, Num 18, pp 1673-1683, issn 0028-4793, 11 p.Article

Prompt versus preemptive intervention for EBV lymphoproliferative diseaseWAGNER, Hans-Joachim; YEE CHUNG CHENG; HULS, M. Helen et al.Blood. 2004, Vol 103, Num 10, pp 3979-3981, issn 0006-4971, 3 p.Article

Chronic Rotavirus Infection in an Infant with Severe Combined Immunodeficiency: Successful Treatment by Hematopoietic Stem Cell TransplantationPATEL, Niraj C; HERTEL, Paula M; HANSON, Imelda C et al.Clinical immunology (Orlando, Fla. Print). 2012, Vol 142, Num 3, pp 399-401, issn 1521-6616, 3 p.Article

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy AdultsDRISCOLL, Timothy A; YU, Lolie C; PING LIU et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5770-5779, issn 0066-4804, 10 p.Article

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantationROUSSEAU, Raphael F; BIAGI, Ettore; GEE, Adrian P et al.Blood. 2006, Vol 107, Num 4, pp 1332-1341, issn 0006-4971, 10 p.Article

  • Page / 1